Screener / SEC EDGAR /CIK 0001821825 /10-K filed Feb 24, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Organon & Co. OGN

Compare with peers Embed
CEO pay, fiscal year to Dec 31, 2025

Joseph Morrissey was paid $21.6M as reported, -$7.1M at the share price

Proxy (DEF 14A)
CEO pay, as reported $21.6M salary, bonus and awards at grant value
CEO pay, actually paid -$7.1M awards valued at the share price
$100 in the shares became $2368 peer group: $15636
CEO pay, 5 years $85.6M up 16% while net income fell 86%

Did pay move with results?

Each line is 100 in 2021 · pay versus performance table, proxy (DEF 14A)

-50050100 20212022202320242025 CEO pay, 2021: 100CEO pay, 2022: 82CEO pay, 2023: -4CEO pay, 2024: 115CEO pay, 2025: -50 CEO pay -50 Net income, 2021: 100Net income, 2022: 68Net income, 2023: 76Net income, 2024: 64Net income, 2025: 14 Net income 14 $100 invested, 2021: 100$100 invested, 2022: 95$100 invested, 2023: 52$100 invested, 2024: 57$100 invested, 2025: 28 $100 invested 28

When the pay line climbs faster than net income and the $100 line, pay rose more than results did; when it falls with them, it followed them. "Actually paid" re-values stock awards at the share price, so it moves with the stock. Numbers as the company tagged them in its proxy.

Pay against results, year by year

Pay versus performance · proxy, filed Apr 24, 2026

Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) $100 became
Dec 31, 2025Joseph Morrissey $21.6M-$7.1M $2368
Dec 31, 2024Kevin Ali $17.1M$16.4M $4805
Dec 31, 2023Kevin Ali $14.8M-$554K $4371
Dec 31, 2022Kevin Ali $13.5M$11.7M $7965
Dec 31, 2021Kevin Ali $18.6M$14.3M $8372

Pay versus performance table of the proxy statement (DEF 14A) filed Apr 24, 2026, as tagged by the company in XBRL. Open the proxy

Pay against free cash flow per share, at peers

Change over the years each proxy covers · pay versus performance table, DEF 14A, and 10-K XBRL

CEO pay, as reported Free cash flow per share » runs past the edge. Pay is salary, bonus and awards at grant value. FCF per share is cash from operations less capital spending, over diluted shares, from the 10-K of the same fiscal year.

OGN: CEO pay rose 16% from FY2021 to FY2025 ($18.6M to $21.6M), while free cash flow per share fell 73% ($7.74 to $2.06). Open the proxy

Sources

The pay versus performance table of the latest proxy statement, as the company tagged it in XBRL.

Also

Cash & buybacks: what the company did with its cash in the same years.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OGN/export.csv") into a cell.

Next:Crypto holdings
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.